Why are most provider-sponsored health plans unprofitable?

The latest stories trending on MedCity News.

Editor's Pick

Top Story Why Are Most Provider-Sponsored Health Plans Unprofitable? The "vast majority" of provider-sponsored health plans are unprofitable, Flare Capital Partners Principal Parth Desai pointed out during a recent interview. He said most of these plans aren't able to cover the large number of lives required to ensure a viable risk pool and maintain a healthy operating margin. Sponsored Content Do you advise self-insured employers? We Want to Hear From You. Presented by MedCity News Last year's inaugural report revealed a dramatic paradigm shift underway in healthcare benefits. What will this year look like?  Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health, healthcare navigation, and more. What Sectors Within Women's Health Are Being Neglected in Terms of Investment? "Health equity & chronic condition management. We have the worst infant and maternal outcomes in the developed world, and it's almost entirely due to social factors and chronic conditions that impact pregnancy. An emphasis on bridging social barriers and preventative care/chronic condition management specifically for women is needed." INVEST 2024 Speaker, Ellen Herlacher Partner of LRVHealth Register Now and Save $300 [ends 3/29]

Featured News

What Are the Challenges Facing the Pharmacy Industry Right Now? The regulatory environment and workforce shortages are plaguing the pharmacy industry, one Walgreens exec shared at the Abarca Forward conference on Tuesday. Startup Lands $150M for Delicate Dance Between Cancer Cells & Immune Cells Clasp Therapeutics' novel T cell engagers could offer advantages over others in this class of cancer immunotherapies. The startup is based on the research of Johns Hopkins University scientist Bert Vogelstein. Breaking Down Barriers to Obesity Care How targeted outreach and heightened engagement can help companies achieve better outcomes

Resources

MedCity Pivot Podcast: A Conversation with Lumen CEO Daniel Tal Mor In this episode of the MedCity Pivot Podcast, we looked deeper into Lumen, a consumer device meant to give people better understanding over how the body burns fat or carbs. We caught up with Daniel Tal Mor, CEO of Lumen, at Vive, and it was intriguing. What was the CEO of a direct-to-consumer company doing at an industry conference where the buyers were generally providers, employers and payers? Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe